Previous studies have shown that berbamine and its analogs can inhibit tumor growth by modulating nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling (Liang et al., 2016; Jia et al., 2017). Here, NFKB1 is linked to neoplasm.